FdaApplication

ANDA 216908

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTP ANDA HOLDINGS LLC
application_typeANDA
approval_date2023-05-31

Products (2)

ProductActive ingredientStrengthDosage form
NAPROXENNAPROXEN375MGTABLET, DELAYED RELEASE;ORAL
NAPROXENNAPROXEN500MGTABLET, DELAYED RELEASE;ORAL

2 products